288 related articles for article (PubMed ID: 25301071)
1. CD44 functions in Wnt signaling by regulating LRP6 localization and activation.
Schmitt M; Metzger M; Gradl D; Davidson G; Orian-Rousseau V
Cell Death Differ; 2015 Apr; 22(4):677-89. PubMed ID: 25301071
[TBL] [Abstract][Full Text] [Related]
2. Role of the Rap2/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling.
Park DS; Seo JH; Hong M; Choi SC
Biochem Biophys Res Commun; 2013 Jun; 436(2):338-43. PubMed ID: 23743195
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains.
Kim J; Han W; Park T; Kim EJ; Bang I; Lee HS; Jeong Y; Roh K; Kim J; Kim JS; Kang C; Seok C; Han JK; Choi HJ
Nat Commun; 2020 Oct; 11(1):5357. PubMed ID: 33097721
[TBL] [Abstract][Full Text] [Related]
4. PTK7 modulates Wnt signaling activity via LRP6.
Bin-Nun N; Lichtig H; Malyarova A; Levy M; Elias S; Frank D
Development; 2014 Jan; 141(2):410-21. PubMed ID: 24353057
[TBL] [Abstract][Full Text] [Related]
5. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs.
Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J
J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053
[TBL] [Abstract][Full Text] [Related]
6. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
7. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
[TBL] [Abstract][Full Text] [Related]
8. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer.
Zhu H; Su Z; Ning J; Zhou L; Tan L; Sayed S; Song J; Wang Z; Li H; Sun Q; Liu S; Sha O; Leng F; Chen X; Lu D
Cell Death Dis; 2021 Oct; 12(10):912. PubMed ID: 34615853
[TBL] [Abstract][Full Text] [Related]
10. Bili inhibits Wnt/beta-catenin signaling by regulating the recruitment of axin to LRP6.
Kategaya LS; Changkakoty B; Biechele T; Conrad WH; Kaykas A; Dasgupta R; Moon RT
PLoS One; 2009 Jul; 4(7):e6129. PubMed ID: 19572019
[TBL] [Abstract][Full Text] [Related]
11. Receptor heterodimerization as a novel mechanism for the regulation of Wnt/β-catenin signaling.
Lee K; Shin Y; Cheng R; Park K; Hu Y; McBride J; He X; Takahashi Y; Ma JX
J Cell Sci; 2014 Nov; 127(Pt 22):4857-69. PubMed ID: 25271056
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells.
Bourguignon LY; Peyrollier K; Gilad E; Brightman A
J Biol Chem; 2007 Jan; 282(2):1265-80. PubMed ID: 17092940
[TBL] [Abstract][Full Text] [Related]
13. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6.
Semënov MV; Tamai K; Brott BK; Kühl M; Sokol S; He X
Curr Biol; 2001 Jun; 11(12):951-61. PubMed ID: 11448771
[TBL] [Abstract][Full Text] [Related]
14. RAB8B is required for activity and caveolar endocytosis of LRP6.
Demir K; Kirsch N; Beretta CA; Erdmann G; Ingelfinger D; Moro E; Argenton F; Carl M; Niehrs C; Boutros M
Cell Rep; 2013 Sep; 4(6):1224-34. PubMed ID: 24035388
[TBL] [Abstract][Full Text] [Related]
15. Waif1/5T4 inhibits Wnt/β-catenin signaling and activates noncanonical Wnt pathways by modifying LRP6 subcellular localization.
Kagermeier-Schenk B; Wehner D; Ozhan-Kizil G; Yamamoto H; Li J; Kirchner K; Hoffmann C; Stern P; Kikuchi A; Schambony A; Weidinger G
Dev Cell; 2011 Dec; 21(6):1129-43. PubMed ID: 22100263
[TBL] [Abstract][Full Text] [Related]
16. In Situ Fucosylation of the Wnt Co-receptor LRP6 Increases Its Endocytosis and Reduces Wnt/β-Catenin Signaling.
Hong S; Feng L; Yang Y; Jiang H; Hou X; Guo P; Marlow FL; Stanley P; Wu P
Cell Chem Biol; 2020 Sep; 27(9):1140-1150.e4. PubMed ID: 32649905
[TBL] [Abstract][Full Text] [Related]
17. Polarized Wnt signaling regulates ectodermal cell fate in Xenopus.
Huang YL; Niehrs C
Dev Cell; 2014 Apr; 29(2):250-7. PubMed ID: 24780739
[TBL] [Abstract][Full Text] [Related]
18. Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.
Lu W; Li Y
J Cell Biochem; 2014 Oct; 115(10):1799-807. PubMed ID: 24905570
[TBL] [Abstract][Full Text] [Related]
19. Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression.
Nam JS; Turcotte TJ; Smith PF; Choi S; Yoon JK
J Biol Chem; 2006 May; 281(19):13247-13257. PubMed ID: 16543246
[TBL] [Abstract][Full Text] [Related]
20. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
Lu W; Lin C; Li Y
Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
